• Skip to primary navigation
  • Skip to main content
SRI InternationalSRI mobile logo

SRI International

SRI International - American Nonprofit Research Institute

  • About
    • Blog
    • Press room
  • Expertise
    • Advanced imaging systems
    • Artificial intelligence
    • Biomedical R&D services
    • Biomedical sciences
    • Computer vision
    • Cyber & formal methods
    • Education and learning
    • Innovation strategy and policy
    • National security
    • Ocean & space
    • Quantum
    • QED-C
    • Robotics, sensors & devices
    • Speech & natural language
    • Video test & measurement
  • Ventures
  • NSIC
  • Careers
  • Contact
  • 日本支社
Show Search
Hide Search
Bios September 8, 2021

Thomas Kilduff

SRI International September 8, 2021

Center Director, Center for Neuroscience

Thomas Kilduff, Ph.D., is an expert in the neurobiology of sleep and wakefulness, sleep disorders, and the biological clock. Kilduff was co-first author on the paper that originally described hypocretin/orexin (Hcrt), a neuropeptide system that stimulates arousal and is involved in wakefulness regulation. Dysfunction of the Hcrt system results in narcolepsy, a sleep disorder characterized by excessive daytime sleepiness and a sudden loss of muscle tone known as cataplexy.

In addition to basic research on sleep, his group conducts in vitro and in vivo pharmacology studies related to the development of new medications for the treatment of sleep disorders. Government agencies, private foundations, and pharmaceutical companies have supported this research. Kilduff has authored or co-authored more than 200 published abstracts, scientific articles, and book chapters.

Kilduff was previously a senior research scientist at Stanford University’s Center for Sleep and Circadian Neurobiology. He has been elected to the board of directors of the Sleep Research Society (SRS) and served as secretary/treasurer for both the SRS and SRS Foundation. He received his Ph.D. in biological sciences from Stanford University. In 2010, Kilduff was named a Fellow of the American Association for the Advancement of Science (AAAS).

Kilduff was named an SRI Fellow in 2010 and a Distinguished Scientist by the SRS in 2017.

View Dr. Kilduff’s publications via PubMed or Google Scholar.

Recent publications

more +

Cerebrospinal Fluid Monoamine Levels in Central Disorders of Hypersomnolence (7/9/2021) - Study objectives: Whether the cause of daytime sleepiness in narcolepsy type 1 (NT1) is a direct consequence of the loss…
Animal Models of Narcolepsy and the Hypocretin/orexin System: Past, Present, and Future (6/11/2021) - Animal models have advanced not only our understanding of the etiology and phenotype of the sleep disorder narcolepsy but have…
Hypocretin/Orexin Receptor Pharmacology and Sleep Phases (5/28/2021) - The hypocretins/orexins are two excitatory neuropeptides, alternately called HCRT1 or orexin-A and HCRT2 or orexin-B, that are the endogenous ligands…

Share this

Facebooktwitterlinkedinmail

Bios, Lab and Center Directors

How can we help?

Once you hit send…

We’ll match your inquiry to the person who can best help you.

Expect a response within 48 hours.

Our privacy policy
Career call to action image

Make your own mark.

Search jobs
Our work

Case studies

Publications

Timeline of innovation

Areas of expertise

Blog

Institute

Leadership

Press room

Media inquiries

Compliance

Privacy policy

Careers

Job listings

Contact

SRI Ventures

Our locations

Headquarters

333 Ravenswood Ave
Menlo Park, CA 94025 USA

+1 (650) 859-2000

Subscribe to our newsletter

日本支社

SRI International

  • Privacy Policy
  • Cookies
  • DMCA
  • Copyright © 2022 SRI International